TIP30 interacts with an estrogen receptor α-interacting coactivator CIA and regulates c-myc transcription

被引:67
作者
Jiang, C
Ito, M
Piening, V
Bruck, K
Roeder, RG
Xiao, H
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
[3] Kobe Univ, Sch Med, Dept Med, Div Hematol Oncol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[4] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M401809200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deregulation of c-myc expression is implicated in the pathogenesis of many neoplasias. Estrogen receptor alpha (ERalpha) can increase the rate of c-myc transcription through the recruitment of a variety of cofactors to the promoter, yet the precise roles of these cofactors in transcription and tumorigenesis are largely unknown. We show here that a putative tumor suppressor TIP30, also called CC3 or Htatip2, interacts with an ERalpha-interacting coactivator CIA. Using chromatin immunoprecipitation assays, we demonstrate that TIP30 and CIA are distinct cofactors that are dynamically associated with the promoter and downstream regions of the c-myc gene in response to estrogen. Both TIP30 and CIA are recruited to the c-myc gene promoter by liganded ERalpha in the second transcription cycle. TIP30 overexpression represses ERalpha-mediated c-myc transcription, whereas TIP30 deficiency enhances c-myc transcription in both the absence and presence of estrogen. Ectopic CIA cooperates with TIP30 to repress ERalpha-mediated c-myc transcription. Moreover, virgin TIP30 knockout mice exhibit increased c-myc expression in mammary glands. Together, these results reveal an important role for TIP30 in the regulation of ERalpha-mediated c-myc transcription and suggest a mechanism for tumorigenesis promoted by TIP30 deficiency.
引用
收藏
页码:27781 / 27789
页数:9
相关论文
共 43 条
  • [1] THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA
    BATTEY, J
    MOULDING, C
    TAUB, R
    MURPHY, W
    STEWART, T
    POTTER, H
    LENOIR, G
    LEDER, P
    [J]. CELL, 1983, 34 (03) : 779 - 787
  • [2] Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor
    Burakov, D
    Crofts, LA
    Chang, CPB
    Freedman, LP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) : 14359 - 14362
  • [3] The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
    Cardiff, RD
    Anver, MR
    Gusterson, BA
    Hennighausen, L
    Jensen, RA
    Merino, MJ
    Rehm, S
    Russo, J
    Tavassoli, FA
    Wakefield, LM
    Ward, JM
    Green, JE
    [J]. ONCOGENE, 2000, 19 (08) : 968 - 988
  • [4] Estrogen receptor null mice: What have we learned and where will they lead us?
    Couse, JF
    Korach, KS
    [J]. ENDOCRINE REVIEWS, 1999, 20 (03) : 358 - 417
  • [5] Couse JF, 1999, ANN ENDOCRINOL-PARIS, V60, P143
  • [6] Cunha GR, 2000, ADV EXP MED BIOL, V480, P93
  • [7] c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
    D'Cruz, CM
    Gunther, EJ
    Boxer, RB
    Hartman, JL
    Sintasath, L
    Moody, SE
    Cox, JD
    Ha, SI
    Belka, GK
    Golant, A
    Cardiff, RD
    Chodosh, LA
    [J]. NATURE MEDICINE, 2001, 7 (02) : 235 - 239
  • [8] ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI
    DIGNAM, JD
    LEBOVITZ, RM
    ROEDER, RG
    [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (05) : 1475 - 1489
  • [9] DUBIK D, 1992, ONCOGENE, V7, P1587
  • [10] The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II
    Ferdous, A
    Gonzalez, F
    Sun, LP
    Kodadek, T
    Johnston, SA
    [J]. MOLECULAR CELL, 2001, 7 (05) : 981 - 991